Skip to main content

Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer

  • Chapter
Cellular Cancer Markers

Part of the book series: Contemporary Biomedicine ((CB,volume 12))

  • 78 Accesses

Abstract

Cancer markers are products of cancer cells that reflect both the less differentiated state of cancer cells from normal (oncodevelopmental markers) and the molecular changes in cancer cells that take place because of activation of cell division or inhibition of the process of programmed cell death (apoptosis). The expression of these markers by cancer cells may be used to identify them as abnormal and as an indication of their malignant potential. Thus, the study of cancer markers may contribute not only to the basic understanding of the process of carcinogenesis and the biology of cancer, but also to the diagnosis and evaluation of the prognosis of patients with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bloom H. J. G. and W. W. Richardson (1957), Br. J. Cancer 2, 359–377.

    Article  Google Scholar 

  • Burke, H. B. and D. E. Hensen (1993), Cancer 72, 3131–3135

    Article  PubMed  CAS  Google Scholar 

  • Carter, C. L., C. Allen, and D. E. Hensen (1989), Cancer 63, 181–187.

    Article  PubMed  CAS  Google Scholar 

  • Chen D. W. and S. Sell. (1994), Tumor markers, in Tietz Textbook of Clinical Chemistry. C. A. Burtis and E. R. Ashwood, eds. 2nd ed. pp. 897–927.

    Google Scholar 

  • Clark, G. M. and W. L. McGuire (1991), Cancer Res. 51, 944–948.

    PubMed  CAS  Google Scholar 

  • Cohen, C., T. Moghazy, D. Sgoutas, and P. D. DeRose (1994), Appl. Immunohistochem. 2, 9–14.

    Google Scholar 

  • Domagala, W., G. Striker, and A. Szadowska (1992), Am. J. Pathol. 141, 1003–1012.

    PubMed  CAS  Google Scholar 

  • Donehower, L. A. and A. Bradley (1993), Biochim. Biophys. Acta 1155, 181–205.

    PubMed  CAS  Google Scholar 

  • Duffy, M. J. (1993), Clin. Biochem. 26, 439–447.

    Article  PubMed  CAS  Google Scholar 

  • Elston, C. W. and I. O. Ellis (1991), Histopathology 19, 403–410.

    Article  PubMed  CAS  Google Scholar 

  • Escot C., C. Theillet, R. Lideriau, et al. (1986), Proc. Natl. Acad. Sci. USA 83, 4834–4838.

    Article  PubMed  CAS  Google Scholar 

  • Eskelinen, M. J., P. K. Lipponen, Y. Collan, and K. J. Syrjanen (1991), Eur. J. Cancer 27, 830–834.

    Google Scholar 

  • Field, J. K. and D. A. Spandidos (1990), Anticancer Res. 10, 1–22.

    PubMed  CAS  Google Scholar 

  • Fisher, E. R., C. Redmond, and B. Fisher (1980), Pathol. Annu. 15, 239–251.

    PubMed  CAS  Google Scholar 

  • Gasparini, G., F. Pozza, and A. L. Harris (1992), J. Natl. Cancer Inst. 85, 1206–1219.

    Article  Google Scholar 

  • Harris, C. C. and M. Hollstein (1993), N. Eng. J. Med. 329, 1318–1327.

    Article  CAS  Google Scholar 

  • Humphrey, P. A., D. W. Franquemont, W. A. Geary, et al. (1994), Appl. Immunohistochem. 2, 22–28.

    Google Scholar 

  • Hurlimann, J. (1993), Path. Res. Pract. 189, 996–1003.

    Article  PubMed  CAS  Google Scholar 

  • Kandalaft, P. L., K. L. Chang, C. W. Ahn, et al. (1993), Cancer 71, 2756–2763.

    Article  PubMed  CAS  Google Scholar 

  • Kramer, B. S. et al. (1993), Ann. Int. Med. 119, 914–923.

    PubMed  CAS  Google Scholar 

  • Logue, L. J. (1993), Clin. Chem. 39, 2435–2438.

    PubMed  CAS  Google Scholar 

  • Lonn, U., S. Lonn, B. Nilsson, and B. Stenkvist (1994), Breast Cancer Res. Treatment 29, 237–245.

    Article  CAS  Google Scholar 

  • Mettlin, C. (1993), Cancer 72, 1050–1055.

    Article  PubMed  CAS  Google Scholar 

  • Miki, Y, J. Swensen, S. Shattuck-Eidens, et al. (1994), Science 266, 66–71.

    Article  PubMed  CAS  Google Scholar 

  • Miller, W. R., R. A. Elton, J. M. Dixon, U. Chetty, and D. M. A. Watson (1990), Br. J. Cancer 61, 263–266.

    Article  PubMed  CAS  Google Scholar 

  • National Cancer Institute Consensus Dev. Confer. Statement on Treatment of Early Stage Breast Cancer (1990), NIH 8(6).

    Google Scholar 

  • Nekulova, M., M. Simickova, L. Pecen, K. Eben, I. Vermousek, P. Stratil, M. Cernoch, and B. Lang (1994), Neoplasma 41, 113–118.

    PubMed  CAS  Google Scholar 

  • Ogura S., S. Abe, N. Sukoh, et al. (1992), Cancer 70, 63–68.

    Article  PubMed  CAS  Google Scholar 

  • Owen, N. C. (1992), New cancer products in Serological Cancer Markers. S. Sell, ed. Humana, Totowa, NJ. pp. 495–523.

    Google Scholar 

  • Sahin, A. A. and N. Sneige (1993) Cancer Bull. 45, 495–499.

    Google Scholar 

  • Schwartz, G. F., R. Schwarting, P. Rabindranauth, and G. C. Finkel (1993), Clin. Chem. 39, 2404–2412.

    PubMed  CAS  Google Scholar 

  • Schwartz, M. K. (1993), Clin. Chem. 39, 2397–2403.

    PubMed  CAS  Google Scholar 

  • Sell, S. and R. Reisfeld (eds.) (1985), Monoclonal Antibodies in Cancer. Humana, Totowa, NJ.

    Google Scholar 

  • Sell, S. and B. Wahren (eds.) (1982), Human Cancer Markers, Humana, Totowa, NJ. Sell, S. (ed.) (1992), Serological Cancer Markers. Humana, Totowa, NJ.

    Google Scholar 

  • Sell, S. (1993), Crit. Revs. Oncogenesis 4, 419–433.

    CAS  Google Scholar 

  • Sell, S. (ed.) (1980), Cancer Markers: Diagnostic and Developmental Significance. Humana, Totowa, NJ.

    Google Scholar 

  • Sidransky D, T. Tokino, S. R. Hamilton, et al. (1992), Science 256, 102–105.

    Article  PubMed  CAS  Google Scholar 

  • Sigurdsson, N., B. Baldetorp, A. Borg, et al. (1990), N. Eng. J. Med. 322, 1045–1053.

    Article  CAS  Google Scholar 

  • Stenmark-Askmalm, M. O. Stal, S. Sullivan, et al. (1994), Eur. J. Cancer 30A, 175–180.

    Article  Google Scholar 

  • Stoschek, C. M. and L. E. King (1986), Cancer Res. 46, 1030–1037.

    Google Scholar 

  • Thor, A. D., D. H. Moore, S. M. Edgerton, et al. (1992), J. Natl. Cancer Inst. 84, 845–855.

    Article  PubMed  CAS  Google Scholar 

  • Yu, H, E. P. Diamandis, and D. J. A. Sutherland (1994), Clin. Biochem. 27, 75–79.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sell, S., Garrett, C.T. (1995). Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer. In: Garrett, C.T., Sell, S. (eds) Cellular Cancer Markers. Contemporary Biomedicine, vol 12. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2381-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2381-6_1

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-000-7

  • Online ISBN: 978-1-4757-2381-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics